Shoulder Innovations has filed a notice of an exempt offering of securities to raise $39,821,690.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Shoulder Innovations is raising $39,821,690.00 in new funding. Sources indicate that as part of senior management Chief Operating Officer, Matthew Ahearn played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Shoulder Innovations
The simplicity of our design–born out of our extensive experience–comes down to the basic notion that traditional fixation techniques aren’t strong enough and don’t last. Our InSet approach to Glenoid fixation is revolutionizing shoulder arthroplasty and, more importantly, improving procedure longevity–ultimately changing patients lives. More than 10 years ago, the Shoulder Innovations team developed InSet™ glenoid fixation technology, creating a robust and stable glenoid platform. With more than 125 cumulative years of shoulder surgical experience, our clinical team can attest to the simplified process of the Shoulder Innovations system. The company’s leadership team has more than a century of cumulative experience engineering and launching a significant portion of the current shoulder replacement systems on the market today. Together, the Shoulder Innovations team will continue their track record of bringing innovative orthopedic solutions that exceed the expectations of patients, surgeons, and healthcare systems.
To learn more about Shoulder Innovations, visit http://shoulderinnovations.com/
Contact:
Matthew Ahearn, Chief Operating Officer
616-566-0286
https://www.linkedin.com/in/matthew-ahearn-a9378a2/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.